These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3850 related articles for article (PubMed ID: 7489563)
1. CD4+ Th0 cell clones, isolated from a metastatic lymph node of a melanoma patient, possess cytolytic function. Imro MA; Castagneto C; Bosco O; Modena P; Lanza L; Puppo F; Filaci G; Indiveri F; Scudeletti M Cancer Immunol Immunother; 1995 Oct; 41(4):210-6. PubMed ID: 7489563 [TBL] [Abstract][Full Text] [Related]
2. Classification of CD4+ T helper cell clones in human melanoma. Goedegebuure PS; Lee KY; Matory YL; Peoples GE; Yoshino I; Eberlein TJ Cell Immunol; 1994 Jun; 156(1):170-9. PubMed ID: 7911074 [TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory effects of CD4+ T helper subsets in human melanoma. Lee KY; Goedegebuure PS; Linehan DC; Eberlein TJ Surgery; 1995 Apr; 117(4):365-72. PubMed ID: 7716716 [TBL] [Abstract][Full Text] [Related]
4. Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy. Kan-Mitchell J; Huang XQ; Steinman L; Oksenberg JR; Harel W; Parker JW; Goedegebuure PS; Darrow TL; Mitchell MS Cancer Immunol Immunother; 1993 Jul; 37(1):15-25. PubMed ID: 8513449 [TBL] [Abstract][Full Text] [Related]
5. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions. Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714 [TBL] [Abstract][Full Text] [Related]
6. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770 [TBL] [Abstract][Full Text] [Related]
7. HLA-B-restricted, CD8+ cytolytic human T cell clones derived from a melanoma-invaded lymph node. Nakashima M; Watanabe T; Koprowski H; Steplewski Z Hybridoma; 1996 Apr; 15(2):147-54. PubMed ID: 8743295 [TBL] [Abstract][Full Text] [Related]
8. Human CD8+ T cell clone regulates autologous CD4+ myelin basic protein specific T cells. Chou YK; Henderikx P; Jones RE; Kotzin B; Hashim GA; Offner H; Vandenbark AA Autoimmunity; 1992; 14(2):111-9. PubMed ID: 1284651 [TBL] [Abstract][Full Text] [Related]
9. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements. Gervois N; Heuze F; Diez E; Jotereau F Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794 [TBL] [Abstract][Full Text] [Related]
10. A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses. Olsen AC; Fossum B; Kirkin AF; Zeuthen J; Gaudernack G Scand J Immunol; 1995 Apr; 41(4):357-64. PubMed ID: 7899823 [TBL] [Abstract][Full Text] [Related]
11. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes. Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759 [TBL] [Abstract][Full Text] [Related]
12. MHC-restricted responses of CD8+ and CD4+ T-cell clones from regional lymph nodes of melanoma patients. Chen Q; Hersey P Int J Cancer; 1992 May; 51(2):218-24. PubMed ID: 1568790 [TBL] [Abstract][Full Text] [Related]
13. Identification of Melanoma-reactive CD4+ T-Cell Subsets From Human Melanoma Draining Lymph Nodes. Zhang M; Graor H; Yan L; Kim J J Immunother; 2016 Jan; 39(1):15-26. PubMed ID: 26641258 [TBL] [Abstract][Full Text] [Related]
17. Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma. LeMay LG; Kan-Mitchell J; Goedegebuure P; Harel W; Mitchell MS Cancer Immunol Immunother; 1993 Aug; 37(3):187-94. PubMed ID: 8101473 [TBL] [Abstract][Full Text] [Related]
18. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer. Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310 [TBL] [Abstract][Full Text] [Related]
19. A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma. Somasundaram R; Swoboda R; Caputo L; Lee A; Jackson N; Marincola FM; Guerry D; Herlyn D Int J Cancer; 2003 Apr; 104(3):362-8. PubMed ID: 12569560 [TBL] [Abstract][Full Text] [Related]
20. Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles. Maccalli C; Mortarini R; Parmiani G; Anichini A Int J Cancer; 1994 Apr; 57(1):56-62. PubMed ID: 7908659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]